Israel Seed Iv L P Sold 9,425 Shares of Finjan Holdings, Inc. (FNJN); Opus Point Partners Management Boosted By $2.84 Million Its Bristol Myers Squibb Co (BMY) Stake

Opus Point Partners Management Llc increased Bristol Myers Squibb Co (BMY) stake by 100% reported in 2017Q3 SEC filing. Opus Point Partners Management Llc acquired 45,000 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Opus Point Partners Management Llc holds 90,000 shares with $5.74 million value, up from 45,000 last quarter. Bristol Myers Squibb Co now has $98.28 billion valuation. The stock decreased 4.39% or $2.76 during the last trading session, reaching $60.05. About 7.49 million shares traded or 39.69% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since January 16, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Israel Seed Iv L P is an insider of Finjan Holdings Inc. That well-know insider lately sold 9,425 shares in the corporation with the trade value amounting to approx. $21,681 US Dollars. The number is according to the filed price of $2.3 for a share. This insider trade, was performed on 14-01-2018. It’s obtainable online at the SEC’s website and can be found at this page. Currently, Israel Seed Iv L P, holds 2.85 million shares, which accounts for 10.30% of Finjan Holdings Inc’s market capitalization.

Among 2 analysts covering Finjan Holdings (NASDAQ:FNJN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Finjan Holdings has $5.0 highest and $4.0 lowest target. $5’s average target is 119.30% above currents $2.28 stock price. Finjan Holdings had 3 analyst reports since May 20, 2016 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, January 2 by FBR Capital. The firm has “Buy” rating by B. Riley & Co given on Friday, May 20.

Finjan Holdings, Inc., through its subsidiaries, operates as a cybersecurity company, provides intellectual property licensing and enforcement services. The company has market cap of $63.17 million. The firm owns a portfolio of patents related to software and hardware technologies that proactively detect malicious code and thereby protects end users from identity and data theft, spyware, malware, phishing, trojans, and other Web and network threats. It has a 6.59 P/E ratio. The Company’s patented technologies are used in specific cybersecurity technology areas, including endpoint/cloud software, Web gateway/Internet infrastructure, networking equipment markets, and mobile security.

The stock decreased 0.87% or $0.02 during the last trading session, reaching $2.28. About 114,657 shares traded. Finjan Holdings, Inc. (NASDAQ:FNJN) has risen 114.51% since January 16, 2017 and is uptrending. It has outperformed by 97.81% the S&P500.

Analysts await Finjan Holdings, Inc. (NASDAQ:FNJN) to report earnings on March, 26. They expect $-0.04 earnings per share, down 123.53% or $0.21 from last year’s $0.17 per share. After $-0.16 actual earnings per share reported by Finjan Holdings, Inc. for the previous quarter, Wall Street now forecasts -75.00% EPS growth.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. The company was downgraded on Friday, August 5 by Morgan Stanley. The stock has “Outperform” rating by Robert W. Baird on Wednesday, April 26. The rating was downgraded by Berenberg to “Hold” on Thursday, August 11. The firm has “Underweight” rating given on Friday, December 18 by Atlantic Securities. Barclays Capital maintained it with “Equal Weight” rating and $75 target in Friday, April 29 report. BMO Capital Markets maintained the shares of BMY in report on Wednesday, August 16 with “Sell” rating. On Wednesday, April 5 the stock rating was maintained by BMO Capital Markets with “Market Perform”. On Tuesday, September 29 the stock rating was upgraded by UBS to “Buy”. The company was maintained on Friday, October 6 by UBS. SunTrust upgraded the shares of BMY in report on Monday, October 30 to “Buy” rating.

Since September 6, 2017, it had 1 buy, and 2 insider sales for $646,385 activity. Another trade for 5,300 shares valued at $335,172 was made by Lynch Thomas J. Jr. on Tuesday, December 12. Another trade for 4,000 shares valued at $249,187 was made by Samuels Theodore R. II on Friday, December 15. $560,400 worth of stock was sold by Caldarella Joseph C on Wednesday, September 6.